British journal of haematology
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial.
Anthony S Stein, Andrew A Lane, Kendra L Sweet, Sumithira Vasu, Alessandra Tosolini, John Katsetos, Marina Konopleva, Naveen Pemmaraju
Published: 202510.1111/bjh.70209
No abstract available for this study.